Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 01, 2020

BUY
$27.51 - $57.29 $16,285 - $33,915
592 Added 8.87%
7,268 $247,000
Q2 2019

Jul 31, 2019

BUY
$39.79 - $67.01 $265,638 - $447,358
6,676 New
6,676 $292,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Public Employees Retirement Association Of Colorado Portfolio

Follow Public Employees Retirement Association Of Colorado and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement Association Of Colorado, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement Association Of Colorado with notifications on news.